Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9111 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.9111 |
High Similarity |
NPD1613 |
Approved |
0.8955 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD4625 |
Phase 3 |
0.8881 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD3027 |
Phase 3 |
0.8686 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8601 |
High Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.854 |
High Similarity |
NPD4908 |
Phase 1 |
0.8477 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8433 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8309 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8286 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8201 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.817 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8134 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8075 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8042 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.8025 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD37 |
Approved |
0.7812 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7786 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7785 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD2801 |
Approved |
0.777 |
Intermediate Similarity |
NPD6099 |
Approved |
0.777 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7763 |
Intermediate Similarity |
NPD1511 |
Approved |
0.773 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7692 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7658 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7635 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7635 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7622 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7606 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7597 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.758 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7548 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7534 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD5494 |
Approved |
0.753 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7518 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7518 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD4626 |
Approved |
0.75 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7484 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7481 |
Intermediate Similarity |
NPD228 |
Approved |
0.747 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7465 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7463 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7463 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7451 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7451 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.744 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7403 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7391 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7376 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7372 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7355 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD27 |
Approved |
0.7349 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7341 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7325 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD7311 |
Approved |
0.731 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD4577 |
Approved |
0.731 |
Intermediate Similarity |
NPD7313 |
Approved |
0.731 |
Intermediate Similarity |
NPD7310 |
Approved |
0.731 |
Intermediate Similarity |
NPD7312 |
Approved |
0.731 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7292 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7289 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7283 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7266 |
Intermediate Similarity |
NPD7157 |
Approved |
0.726 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7259 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7251 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7251 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD4678 |
Approved |
0.725 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.72 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7185 |
Intermediate Similarity |
NPD290 |
Approved |
0.7183 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7174 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7161 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7117 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7111 |
Intermediate Similarity |
NPD968 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7102 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7097 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7091
|
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |